| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $14.4M | -39.9% |
| Operating Income | -$43.7M | -21.9% |
| Interest Expense | $6.5M | +4.1% |
| Pre-tax Income | -$31.4M | +49.4% |
| Income Tax | $179K | — |
| Net Income | -$31.6M | +49.1% |
| EPS (Basic) | -$3.95 | -234.7% |
| EPS (Diluted) | -$3.95 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -21.7% |
| Current Assets | $4.6M | -32.3% |
| Total Assets | $70.7M | -21.0% |
| Current Liabilities | $6.4M | -33.7% |
| Long-term Debt | $22K | -100.0% |
| Total Liabilities | $7.5M | -90.4% |
| Stockholders' Equity | $63.2M | +490.2% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.6M | +12.0% |
| Capital Expenditures | $124K | +40.9% |
| Investing Cash Flow | -$2.0M | +72.6% |
| Financing Cash Flow | $24.5M | +31.8% |
| Free Cash Flow | -$23.8M | +11.9% |
| -234.7% |